GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 4,990.00
-190.00 (-3.67%)
At close: Apr 29, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 165.84 billion as of April 30, 2026. Its market cap has increased by 319.61% in one year.
Market Cap
165.84B
Enterprise Value
161.35B
Revenue
10.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,990.00
Market Cap Chart
Since November 8, 2021, GENINUS's market cap has increased from 145.65B to 165.84B, an increase of 13.86%. That is a compound annual growth rate of 2.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 165.84B | 42.07% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 455.23B |
| 3billion | 437.36B |
| Inventera | 180.12B |
| Cytogen | 132.19B |
| HLB Panagene | 96.63B |
| Green Cross Medical Science | 84.68B |
| Protia | 63.61B |
| Seoulin Bioscience | 56.93B |